Jia HQ - Search Results

1

Characteristics and Significance of Tertiary Lymphoid Structures Based on Molecular Subtypes in Endometrial Cancer.

Jia HQ, Zhang SP, Chen Y, Qiao YH, Yao YF, Zhang XY, Wu SY, Song YL, Xing XM. Jia HQ, et al. Int J Gynecol Pathol. 2024 Nov 1;43(6):595-604. doi: 10.1097/PGP.0000000000001027. Epub 2024 Feb 23. Int J Gynecol Pathol. 2024. PMID: 39418587

2

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast.

Jia H, Zhao P, Chen Z, Wang G, Dong X, Xing X, Tan X, Wang C. Jia H, et al. Breast Cancer Res Treat. 2022 May;193(1):111-120. doi: 10.1007/s10549-022-06553-z. Epub 2022 Mar 8. Breast Cancer Res Treat. 2022. PMID: 35260954 Free PMC article.

3

Silencing TRAIP suppresses cell proliferation and migration/invasion of triple negative breast cancer via RB-E2F signaling and EMT.

Zheng Y, Jia H, Wang P, Liu L, Chen Z, Xing X, Wang J, Tan X, Wang C. Zheng Y, et al. Cancer Gene Ther. 2023 Jan;30(1):74-84. doi: 10.1038/s41417-022-00517-7. Epub 2022 Sep 5. Cancer Gene Ther. 2023. PMID: 36064576 Free PMC article.

4

Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients.

Chen Z, Jia H, Zhang H, Chen L, Zhao P, Zhao J, Fu G, Xing X, Li Y, Wang C. Chen Z, et al. Breast Cancer Res Treat. 2023 Nov;202(2):313-323. doi: 10.1007/s10549-023-07079-8. Epub 2023 Aug 28. Breast Cancer Res Treat. 2023. PMID: 37639064 Free PMC article.

5

Presence, Subtypes, and Prognostic Significance of Tertiary Lymphoid Structures in Urothelial Carcinoma of the Bladder.

Ma G, Jia H, Zhang G, Liang Y, Dong X, Fu G, Wang X, Niu H. Ma G, et al. Oncologist. 2024 Feb 2;29(2):e248-e258. doi: 10.1093/oncolo/oyad283. Oncologist. 2024. PMID: 37874923 Free PMC article.

6

Next-generation sequencing-based analysis of homologous recombination repair gene variant in ovarian cancer.

Song Y, Ran W, Jia H, Yao Q, Li G, Chen Y, Wang X, Xiao Y, Sun M, Lu X, Xing X. Song Y, et al. Heliyon. 2024 Jan 5;10(2):e23684. doi: 10.1016/j.heliyon.2023.e23684. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38298632 Free PMC article.

7

Integrated Transcriptomic Landscape and Deep Learning Based Survival Prediction in Uterine Sarcomas.

Song Y, Li G, Zhang Z, Liu Y, Jia H, Zhang C, Wang J, Hu Y, Hao F, Liu X, Xie Y, Ma D, Li G, Tai Z, Xing X. Song Y, et al. Cancer Res Treat. 2024 Jul 10. doi: 10.4143/crt.2024.343. Online ahead of print. Cancer Res Treat. 2024. PMID: 38993092 Free article.

8

An integrated radiopathomics machine learning model to predict pathological response to preoperative chemotherapy in gastric cancer.

Song Y, Liu S, Liu X, Jia H, Shi H, Liu X, Hao D, Wang H, Xing X. Song Y, et al. Acad Radiol. 2024 Aug 29:S1076-6332(24)00578-6. doi: 10.1016/j.acra.2024.08.014. Online ahead of print. Acad Radiol. 2024. PMID: 39214816

9

p53 Immunohistochemistry staining patterns and prognosis significance in 212 cases of non-endometrioid endometrial cancer.

Jia H, Wu S, Ma G, Yang P, Li X, Zeng M, Ji X, Xing X. Jia H, et al. Pathol Res Pract. 2024 Nov;263:155595. doi: 10.1016/j.prp.2024.155595. Epub 2024 Sep 18. Pathol Res Pract. 2024. PMID: 39316989

10

Gefitinib Reverses PD-L1-Mediated Immunosuppression Induced by long-term Glutamine blockade in Bladder Cancer.

Ma G, Jia H, Li Z, Zhang X, Wang L, Zhang Z, Xiao Y, Liang Z, Li D, Chen Y, Tian X, Wang Y, Liang Y, Niu H. Ma G, et al. Cancer Immunol Res. 2024 Oct 29. doi: 10.1158/2326-6066.CIR-24-0039. Online ahead of print. Cancer Immunol Res. 2024. PMID: 39470699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters